Aduhelm's accelerated approval for the treatment of Alzheimer's Disease

Aduhelm's accelerated approval for the treatment of Alzheimer's Disease

Madam, despite the life-threatening manifestations that Alzheimer's disease (AD) possesses, to date, only five medical treatments have been approved for AD, which involve two classes of drugs that merely control the symptoms rather than altering the course of the disease. Moreover, in the last...

Full description

Bibliographic Details
Main Authors:	Aayat Ellahi Buksh, Fahd Shaikh, Hasnain Mankani
Format:	Article
Language:	English
Published:	Pakistan Medical Association 2022-04-01
Series:	Journal of the Pakistan Medical Association
Online Access:	https://www.ojs.jpma.org.pk/index.php/public_html/article/view/4368

Similar Items

Myocarditis following administration of COVID-19 Vaccine – Should we be worried?
by: Aayat Ellahi Buksh, et al.
Published: (2022-08-01)

The effect of vitamin D deficiency on Inflammatory disorders
by: Naz Elahi, et al.
Published: (2023-04-01)

An update on the novel and approved drugs for Alzheimer disease
by: Hassan Ahmad Alhazmi, et al.
Published: (2022-12-01)

The accelerated approval process in oncology : an examination of the conversion rate of approved therapies to full approval
by: Kim, Jean Jinsun
Published: (2007)

Accelerated Aging Characterizes the Early Stage of Alzheimer’s Disease
by: Alessandro Leparulo, et al.
Published: (2022-01-01)

Anti-Cholinesterase Combination Drug Therapy as a Potential Treatment for Alzheimer’s Disease
by: Hafsa Amat-ur-Rasool, et al.
Published: (2021-02-01)

DNA Damage-Induced Neurodegeneration in Accelerated Ageing and Alzheimer’s Disease
by: Heling Wang, et al.
Published: (2021-06-01)

Development of an accelerated cellular model for early changes in Alzheimer’s disease
by: Huijing Xue, et al.
Published: (2023-10-01)

Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease
by: Caitlin V. M. L. Jie, et al.
Published: (2021-01-01)

Clinical development time is shorter for new anticancer drugs approved via accelerated approval in the US or via conditional approval in the EU
by: Ebru Demirci, et al.
Published: (2023-07-01)

Treatment for Alzheimer's disease.
by: Wilcock, G
Published: (2000)

Treatment for Alzheimer's diseases
by: Nina Arkadyevna Tyuvina, et al.
Published: (2015-10-01)

True brachial artery aneurysm: A systematic review
by: Syed Muhammad Hammad Alam, et al.
Published: (2024-01-01)

True brachial artery aneurysm: A systematic review
by: Syed Muhammad Hammad Alam, et al.
Published: (2024-01-01)

Technopreneurship : the successful entrepreneur in the new economy /
by: 348658 Mankani, Daniel
Published: (2003)

The Alzheimer's Cell Atlas (TACA): A single‐cell molecular map for translational therapeutics accelerator in Alzheimer's disease
by: Yadi Zhou, et al.
Published: (2022-01-01)

Alzheimer's research after full approval of lecanemab: impetus and variety
by: Timothy Daly
Published: (2024-01-01)

In Silico Design of Dual-Binding Site Anti-Cholinesterase Phytochemical Heterodimers as Treatment Options for Alzheimer’s Disease
by: Hafsa Amat-ur-Rasool, et al.
Published: (2021-12-01)

Anatomical and Functional Outcomes of Scleral Buckling for Rhegmatogenous Retinal Detachment Surgeries.
by: Muhammad Ali Haider, et al.
Published: (2022-12-01)

Accelerating diversity in Alzheimer's disease research by partnering with a community advisory board
by: Alex Pena‐Garcia, et al.
Published: (2023-04-01)

Influence of Acetylcholine Esterase Inhibitors and Memantine, Clinically Approved for Alzheimer’s Dementia Treatment, on Intestinal Properties of the Mouse
by: Vu Thu Thuy Nguyen, et al.
Published: (2021-01-01)

Clioquinol for the treatment of Alzheimer's Disease.
by: Jenagaratnam, L, et al.
Published: (2006)

Perspectives of Alzheimer's disease treatments.
by: Davis, J, et al.
Published: (2008)

Effective treatment for Alzheimer's disease?
Published: (2016-05-01)

GALANTHAMINE AND THE TREATMENT OF ALZHEIMERS-DISEASE
by: Wilcock, G, et al.
Published: (1993)

ALZHEIMER’S DISEASE: DIAGNOSIS AND TREATMENT
by: A. A. Naumenko, et al.
Published: (2016-12-01)

Alzheimer’s disease: diagnosis and treatment
by: I. S. Preobrazhenskaya
Published: (2014-01-01)

Preparation of organotypic brain slice cultures for the study of Alzheimer’s disease [version 1; referees: 2 approved]
by: Cara L. Croft, et al.
Published: (2018-05-01)

The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials
by: Wenxue Wu, et al.
Published: (2023-11-01)

Protocol: the complexity of informal caregiving for Alzheimer's disease and related dementias in rural South Africa [version 1; peer review: 1 approved, 2 approved with reservations]
by: Farirai Rusere, et al.
Published: (2022-08-01)

KIF5A and KLC1 expression in Alzheimer’s disease: relationship and genetic influences [version 2; peer review: 2 approved, 1 approved with reservations]
by: Seth Love, et al.
Published: (2019-06-01)

Mortality Predictors in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
by: Sadhna Mankani, et al.
Published: (2022-12-01)

FDA Accelerated Approval for Malignant Hematology and Oncology Indications in the Canadian Environment
by: Cheryl Ho, et al.
Published: (2022-01-01)

Constructional apraxia in Alzheimer's disease: association with occipital lobe pathology and accelerated cognitive decline.
by: Smith, M, et al.
Published: (2001)

Skeletal muscle atrophy‐induced hemopexin accelerates onset of cognitive impairment in Alzheimer's disease
by: Tsukasa Nagase, et al.
Published: (2021-12-01)

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease
by: Nicolai Franzmeier, et al.
Published: (2024-01-01)

A Federated Learning Model Based on Hardware Acceleration for the Early Detection of Alzheimer’s Disease
by: Kasem Khalil, et al.
Published: (2023-10-01)

Epigenetic and non-epigenetic mechanisms in the accelerated cellular aging in late-onset Alzheimer’s disease
by: Kajal Rawat, et al.
Published: (2023-04-01)

Accelerated aging-related transcriptome alterations in neurovascular unit cells in the brain of Alzheimer’s disease
by: Yan Zhao, et al.
Published: (2022-08-01)

Increased neutrophils in inflammatory bowel disease accelerate the accumulation of amyloid plaques in the mouse model of Alzheimer’s disease
by: Ryusei Kaneko, et al.
Published: (2023-03-01)